B12 Injection vs NSI-189
A side-by-side research comparison of B12 Injection and NSI-189 across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | B12 Injection | NSI-189 |
|---|---|---|
| Full name | Methylcobalamin (Vitamin B12) Injectable | NSI-189 Phosphate (Neurogenic Compound) |
| Category | Cognitive & Nootropic | Cognitive & Nootropic |
| Status | Prescribed / OTC | Investigational |
| Mechanism | Cofactor for methionine synthase (DNA methylation) and methylmalonyl-CoA mutase (energy metabolism). Supports myelin synthesis, neurotransmitter production, and red blood cell formation. | Stimulates hippocampal neural stem cell proliferation and differentiation via Akt/CREB/BDNF signaling. Increases hippocampal volume visible on MRI. |
| Molecular weight | 1344.38 Da | 366.4 Da |
| Half-life | ~6 days | 18-22 hours |
| Bioavailability | ~100% IM/SC | High (oral) |
| Typical dose | 1000-5000 mcg | 40-80 mg |
| Frequency | 1-3x per week | Once daily |
| Route | Intramuscular or subcutaneous injection | Oral |
B12 Injection reported benefits
- Increased energy
- Improved cognitive function
- Nerve repair
- Red blood cell production
- Better sleep
- Mood enhancement
NSI-189 reported benefits
- Hippocampal neurogenesis
- Measurable brain volume increase
- Cognitive enhancement
- Antidepressant effects
- Long-term neural benefit
Related comparisons
Research and educational reference only. Not medical advice.